Silverback Therapeutics shares owned by Levin Capital Strategies
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Levin Capital Strategies
from 13F filings
Historical chart of Levin Capital Strategies investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Levin Capital Strategies consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Silverback Therapeutics by Levin Capital Strategies
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $286k | 52k | 5.48 |
2023-09-30 | $507k | 134k | 3.78 |
2023-06-30 | $1.1M | 169k | 6.70 |
2023-03-31 | $914k | 140k | 6.51 |
2022-12-31 | $333k | 39k | 8.53 |